Počet záznamů: 1
Mitochondrially Targeted alpha-Tocopheryl Succinate Is Antiangiogenic: Potential Benefit Against Tumor Angiogenesis but Caution Against Wound Healing
SYS 0369479 LBL 03478^^^^^2200541^^^450 005 20240103200051.2 014 $a 000296588900002 $2 WOS 017 70
$a 10.1089/ars.2011.4192 $2 DOI 100 $a 20120312d m y slo 03 ba 101 0-
$a eng $d eng 102 $a US 200 1-
$a Mitochondrially Targeted alpha-Tocopheryl Succinate Is Antiangiogenic: Potential Benefit Against Tumor Angiogenesis but Caution Against Wound Healing 215 $a 13 s. 463 -1
$1 001 cav_un_epca*0258087 $1 011 $a 1523-0864 $e 1557-7716 $1 200 1 $a Antioxidants & Redox Signaling $v Roč. 15, č. 12 (2011), s. 2923-2935 $1 210 $c Mary Ann Liebert 610 0-
$a Analogs of alpha-tocopheryl succinate 610 0-
$a MitoVES 610 0-
$a inhibition of angiogenesis 700 -1
$3 cav_un_auth*0250927 $a Rohlena $b Jakub $i Laboratoř molekulární terapie $j Laboratory of Molecular Therapy $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $4 070 $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0243250 $a Dong $b L.-F. $y AU $4 070 701 -1
$3 cav_un_auth*0277400 $a Klučková $b Katarína $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $4 070 $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0243053 $a Zobalová $b Renata $i Laboratoř molekulární terapie $j Laboratory of Molecular Therapy $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $x Z $4 070 $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0250930 $a Goodwin $b J. $y AU $4 070 701 -1
$3 cav_un_auth*0277401 $a Tilly $b D. $y AU $4 070 701 -1
$3 cav_un_auth*0258703 $a Štursa $b Jan $i 970/97 $j Scientific-Service Teams: Bioorganic Chemistry of Saccharides, Glycoconjugates, and Delivery Systems for Target Therapy $k 970/97 $l 970/97 $p UOCHB-X $4 070 $T Ústav organické chemie a biochemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0242926 $a Pecinová $b Alena $i Bioenergetika $j Bioenergetics $p FGU-C $w Laboratory of Bioenergetics $4 070 $T Fyziologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0276357 $a Philimonenko $b Anatoly $i Oddělení biologie buněčného jádra $j Laboratory of Biology of the Cell Nucleus $k 25 $l 25 $p UMG-J $w Laboratory of Biology of the Cell Nucleus $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0051818 $a Hozák $b Pavel $i Oddělení biologie buněčného jádra $j Laboratory of Biology of the Cell Nucleus $k 25 $l 25 $p UMG-J $w Laboratory of Biology of the Cell Nucleus $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0245217 $a Banerjee $b J. $y US $4 070 701 -1
$3 cav_un_auth*0103588 $a Ledvina $b Miroslav $i 970/97 $j Scientific-Service Teams: Bioorganic Chemistry of Saccharides, Glycoconjugates, and Delivery Systems for Target Therapy $k 970/97 $l 970/97 $p UOCHB-X $4 070 $T Ústav organické chemie a biochemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0277402 $a Sen $b Ch.K. $y US $4 070 701 -1
$3 cav_un_auth*0104200 $a Houštěk $b Josef $i Bioenergetika $j Bioenergetics $p FGU-C $w Laboratory of Bioenergetics $4 070 $T Fyziologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0280344 $a Coster $b M.J. $y AU $4 070 701 -1
$3 cav_un_auth*0239896 $a Neužil $b Jiří $i Laboratoř molekulární terapie $j Laboratory of Molecular Therapy $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $z G $4 070 $T Biotechnologický ústav AV ČR, v. v. i.
Počet záznamů: 1